82 reports of this reaction
1.2% of all CAPSAICIN reports
#16 most reported adverse reaction
HYPOAESTHESIA is the #16 most commonly reported adverse reaction for CAPSAICIN, manufactured by Averitas Pharma Inc. There are 82 FDA adverse event reports linking CAPSAICIN to HYPOAESTHESIA. This represents approximately 1.2% of all 6,703 adverse event reports for this drug.
Patients taking CAPSAICIN who experience hypoaesthesia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOAESTHESIA is a less commonly reported adverse event for CAPSAICIN, but still significant enough to appear in the safety profile.
In addition to hypoaesthesia, the following adverse reactions have been reported for CAPSAICIN:
The following drugs have also been linked to hypoaesthesia in FDA adverse event reports:
HYPOAESTHESIA has been reported as an adverse event in 82 FDA reports for CAPSAICIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOAESTHESIA accounts for approximately 1.2% of all adverse event reports for CAPSAICIN, making it a notable side effect.
If you experience hypoaesthesia while taking CAPSAICIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.